Inhibition of inflammatory angiogenesis in rats by loco-regional administration of hydrocortisone and protamine.
We have studied the antiangiogenetic effects of hydrocortisone and protamine given intra-arterially. The cornea of male, Sprague-Dawley rats were cauterized with silver nitrate. The following treatments were given: 30 micrograms hydrocortisone topical (t.p.), b.i.d., 50 mg/kg/day intraperitoneally (i.p.) or intra-arterially (i.a.), 10 mg/kg/day protamine i.p. or i.a. Saline was administered to the control groups. In separate experiments we also evaluated the anti-inflammatory effects of hydrocortisone, i.p., on the cauterized corneas. Five days after cauterization, the animals were killed, exsanguinated and India ink was injected to show the network of neovessels. The percentage area of the cornea covered by neovessels was measured morphometrically and evaluated statistically. Hydrocortisone t.p. (-84%), i.a. (-60%) and protamine i.a. (-44%) significantly inhibited angiogenesis in the cauterized cornea. Either drugs, i.p., had any antiangiogenetic effects, but hydrocortisone significantly reduced cell infiltration of the corneas. The results suggest that locoregional administration of antiangiogenetic drugs might be clinically useful.
Foschi
D
D
First Department of Surgery, University of Milan, Ospedale Maggiore Policlinico IRCCS, Italy.
Castoldi
L
L
Corsi
F
F
Radaelli
E
E
Trabucchi
E
E
D000818:Animals; D002425:Cautery; D003315:Cornea / Q000473:pathology; D006854:Hydrocortisone / Q000008:administration & dosage / Q000627:therapeutic use*; D007249:Inflammation / Q000473:pathology / Q000517:prevention & control*; D007269:Injections, Intra-Arterial; D007274:Injections, Intraperitoneal; D008297:Male; D009389:Neovascularization, Pathologic / Q000473:pathology / Q000517:prevention & control*; D011479:Protamines / Q000008:administration & dosage / Q000627:therapeutic use*; D051381:Rats; D017207:Rats, Sprague-Dawley
D011479:Protamines; D006854:Hydrocortisone